Bisdemethoxycurcumin inhibits Wnt/β-catenin pathway by increasing WIF-1 expression, which subsequently leads to suppression of TGF-β1-induced EMT migration. - GreenMedInfo Summary
Abstract Title:
Abstract Source:
Abstract:
Study Type : In Vitro Study
Additional Links
Diseases : Carcinoma: Non-Small-Cell Lung : CK(631) : AC(388), Lung Cancer : CK(2308) : AC(1333), Lung Cancer: Metastatic : CK(52) : AC(21)
Pharmacological Actions : Anti-metastatic : CK(1972) : AC(2051), Wnt/β-catenin pathway down-regulation : CK(94) : AC(56)